Andreas Imdahl

Summary

Affiliation: University of Freiburg
Country: Germany

Publications

  1. ncbi Genesis and pathophysiology of lower gastrointestinal bleeding
    A Imdahl
    Department of Surgery, University Hospital of Freiburg, Hugstetterstrasse 55, 79106 Freiburg, Germany
    Langenbecks Arch Surg 386:1-7. 2001
  2. ncbi [Resection of combined or sequential lung and liver metastases of colorectal cancer: indication for everyone?]
    A Imdahl
    Abteilung Allgemein und Viszeralchiurgie, Chirurgische Universitätsklinik Freiburg, Hugstetterstrasse 55, 79106 Freiburg, Germany
    Zentralbl Chir 130:539-43. 2005
  3. ncbi [Laparoscopic cholecystectomy is the current standard intervention]
    Andreas Imdahl
    Abteilung Allgemein und Viszeralchirurgie Chirurgische Universitätsklinik Freiburg
    MMW Fortschr Med 147:22-5. 2005
  4. ncbi [Preoperative chemoradiation in esophageal cancer: experience of a single center in 102 patients]
    A Imdahl
    Chirurgische Klinik, Abteilung Allgemein und Viszeralchirurgie mit Poliklinik, Universitatsklinikum Freiburg, Freiburg
    Zentralbl Chir 129:350-5. 2004
  5. ncbi Impact of FDG-PET for staging of oesophageal cancer
    Andreas Imdahl
    Department of Surgery, University Hospital of Freiburg, Hugstetterstrasse 55, 79106 Freiburg, Germany
    Langenbecks Arch Surg 389:283-8. 2004
  6. ncbi [Blunt abdominal trauma. Remain alert even when there are few initial symptoms!]
    A Imdahl
    Abt. Allgemein- und Viszeralchirurgie mit Poliklinik, Chirurgische Univ.-Klinik Freiburg
    MMW Fortschr Med 145:41-3. 2003
  7. ncbi Predictive factors for response to neoadjuvant therapy in patients with oesophageal cancer
    A Imdahl
    Department of Surgery, Division of General Surgery, University of Freiburg, Hugstetterstrasse 55, 79106 Freiburg, Germany
    Eur J Cardiothorac Surg 21:657-63. 2002
  8. ncbi Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesions
    A Imdahl
    Department of Thoracic Surgery, Universitatsklinikum Freiburg, Hugstetterstrasse 55, D 79106 Freiburg, Germany
    Eur J Cardiothorac Surg 20:324-9. 2001
  9. ncbi Impact of neoadjuvant therapy of perioperative morbidity in patients with esophageal cancer
    Andreas Imdahl
    Department of Surgery, Division of General Surgery, University Hospital of Freiburg, Hugsterstrasse 55, D 79106 Freiburg, Germany
    Am J Surg 187:64-8. 2004
  10. ncbi Detection of lymph node involvement by cytokeratin immunohistochemistry is an independent prognostic factor after curative resection of esophageal cancer
    Goran Marjanovic
    Department of Surgery, University of Freiburg, Hugstetter Strasse 55, 79106, Freiburg, Germany
    J Gastrointest Surg 15:29-37. 2011

Collaborators

Detail Information

Publications17

  1. ncbi Genesis and pathophysiology of lower gastrointestinal bleeding
    A Imdahl
    Department of Surgery, University Hospital of Freiburg, Hugstetterstrasse 55, 79106 Freiburg, Germany
    Langenbecks Arch Surg 386:1-7. 2001
    ..Therefore, prompt resuscitation is required in many LGB patients before diagnostic procedures are initiated...
  2. ncbi [Resection of combined or sequential lung and liver metastases of colorectal cancer: indication for everyone?]
    A Imdahl
    Abteilung Allgemein und Viszeralchiurgie, Chirurgische Universitätsklinik Freiburg, Hugstetterstrasse 55, 79106 Freiburg, Germany
    Zentralbl Chir 130:539-43. 2005
    ..Therefore, we retrospectively analysed data of patients in whom sequential hepatic and pulmonary resection for metastases was performed...
  3. ncbi [Laparoscopic cholecystectomy is the current standard intervention]
    Andreas Imdahl
    Abteilung Allgemein und Viszeralchirurgie Chirurgische Universitätsklinik Freiburg
    MMW Fortschr Med 147:22-5. 2005
    ....
  4. ncbi [Preoperative chemoradiation in esophageal cancer: experience of a single center in 102 patients]
    A Imdahl
    Chirurgische Klinik, Abteilung Allgemein und Viszeralchirurgie mit Poliklinik, Universitatsklinikum Freiburg, Freiburg
    Zentralbl Chir 129:350-5. 2004
    ..However, it remains open, whether neoadjuvant therapy leads to a downstaging of lymph node involvement, as histological confirmation in clinically positive lymph node is seldom performed prospectively...
  5. ncbi Impact of FDG-PET for staging of oesophageal cancer
    Andreas Imdahl
    Department of Surgery, University Hospital of Freiburg, Hugstetterstrasse 55, 79106 Freiburg, Germany
    Langenbecks Arch Surg 389:283-8. 2004
    ..The aim of the investigation was the assessment of positron emission tomography for detection of M1 disease...
  6. ncbi [Blunt abdominal trauma. Remain alert even when there are few initial symptoms!]
    A Imdahl
    Abt. Allgemein- und Viszeralchirurgie mit Poliklinik, Chirurgische Univ.-Klinik Freiburg
    MMW Fortschr Med 145:41-3. 2003
  7. ncbi Predictive factors for response to neoadjuvant therapy in patients with oesophageal cancer
    A Imdahl
    Department of Surgery, Division of General Surgery, University of Freiburg, Hugstetterstrasse 55, 79106 Freiburg, Germany
    Eur J Cardiothorac Surg 21:657-63. 2002
    ....
  8. ncbi Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesions
    A Imdahl
    Department of Thoracic Surgery, Universitatsklinikum Freiburg, Hugstetterstrasse 55, D 79106 Freiburg, Germany
    Eur J Cardiothorac Surg 20:324-9. 2001
    ..The impact of the (2-(fluorine-18)-fluoro-2-2deoxy-D-glucose)-positron emission tomography ((18)F-FDG-PET) for discrimination of pulmonary lesions was evaluated in a single centre prospective study...
  9. ncbi Impact of neoadjuvant therapy of perioperative morbidity in patients with esophageal cancer
    Andreas Imdahl
    Department of Surgery, Division of General Surgery, University Hospital of Freiburg, Hugsterstrasse 55, D 79106 Freiburg, Germany
    Am J Surg 187:64-8. 2004
    ..Therefore, postoperative morbidity was retrospectively investigated in 82 patients with an esophageal cancer who received preoperative radiochemotherapy...
  10. ncbi Detection of lymph node involvement by cytokeratin immunohistochemistry is an independent prognostic factor after curative resection of esophageal cancer
    Goran Marjanovic
    Department of Surgery, University of Freiburg, Hugstetter Strasse 55, 79106, Freiburg, Germany
    J Gastrointest Surg 15:29-37. 2011
    ..To assess the role of nodal micrometastases, we performed immunohistochemical analyses of LN after resection of node-negative esophageal cancers and correlated the results with survival...
  11. ncbi Outcome after resection of hepatic and pulmonary metastases of colorectal cancer
    Hannes Neeff
    Department of General Surgery, University of Freiburg, Freiburg, Germany
    J Gastrointest Surg 13:1813-20. 2009
    ..We therefore evaluated survival of patients who underwent sequential resection of hepatic and pulmonary metastases under potentially curative intention...
  12. ncbi Non-invasive differentiation of pancreatic lesions: is analysis of FDG kinetics superior to semiquantitative uptake value analysis?
    Egbert U Nitzsche
    Department of Radiology, Albert Ludwigs University, Medical Center, Freiburg, Germany
    Eur J Nucl Med Mol Imaging 29:237-42. 2002
    ..This approach yields results superior to those obtained from a semiquantitative analysis of pancreatic lesions...
  13. ncbi [Predictive factors in esophageal cancer after neoadjuvant therapy]
    Gabor Bognar
    Semmelweis Egyetem, II sz Sebészeti Klinika, Budapest
    Magy Seb 59:20-6. 2006
    ....
  14. ncbi Sentinel lymph node biopsy in colon cancer: a prospective multicenter trial
    Andreas E Bembenek
    Department of Surgery and Surgical Oncology, Robert Rossle Klinik, Charite University Medicine Berlin, Campus Buch at HELIOS Klinikum Berlin, Lindenberger Weg 80, 13125 Berlin, Germany
    Ann Surg 245:858-63. 2007
    ..The purpose of this prospective multicenter trial was to evaluate its clinical value to predict the nodal status and identify factors that influence these results...
  15. ncbi Possible role of human papilloma virus infection in response to neoadjuvant therapy in patients with esophageal cancer
    Gabor Bognar
    2nd Department of Surgery, Semmelweis University Budapest, Budapest, Hungary
    Hepatogastroenterology 55:93-7. 2008
    ..Complete pathological response has been found in 30% of cases after neoadjuvant chemo-radiation (CRX). The aim of this study was to discover a possible relation between HPV-infection and response...